These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9311599)

  • 1. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver.
    Baba M; Yamamoto R; Iishi H; Tatsuta M
    Int J Cancer; 1997 Sep; 72(5):815-20. PubMed ID: 9311599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo electroporetic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats.
    Baba M; Iishi H; Tatsuta M
    Int J Cancer; 2000 Jan; 85(2):260-6. PubMed ID: 10629087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
    Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
    Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
    Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide treatment of ras-induced tumors in nude mice.
    Wickstrom E
    Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM; Simile MM; Feo F
    Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse.
    Buchmann A; Mahr J; Bauer-Hofmann R; Schwarz M
    Mol Carcinog; 1989; 2(3):121-5. PubMed ID: 2675901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association.
    Kaji I; Tatsuta M; Iishi H; Baba M; Inoue A; Kasugai H
    Int J Cancer; 2001 Aug; 93(3):441-4. PubMed ID: 11433412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene.
    Hayashi S; Mori I; Nonoyama T; Mitsumori K
    Toxicol Pathol; 1998; 26(4):556-61. PubMed ID: 9715515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
    Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
    Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species.
    Boivin-Angèle S; Lefrançois L; Froment O; Spiethoff A; Bogdanffy MS; Wegener K; Wesch H; Barbin A; Bancel B; Trépo C; Bartsch H; Swenberg J; Marion MJ
    Int J Cancer; 2000 Jan; 85(2):223-7. PubMed ID: 10629081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1 mice to N-nitrosodiethylamine (DEN).
    Richardson KK; Rexroat MA; Helvering LM; Copple DM; Richardson FC
    Carcinogenesis; 1992 Jul; 13(7):1277-9. PubMed ID: 1638698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986.
    Richardson KK; Helvering LM; Copple DM; Rexroat MA; Linville DW; Engelhardt JA; Todd GC; Richardson FC
    Carcinogenesis; 1992 Jun; 13(6):935-41. PubMed ID: 1350949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
    Carcinogenesis; 1993 Dec; 14(12):2601-4. PubMed ID: 7903604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
    Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He mice.
    Bauer-Hofmann R; Klimek F; Buchmann A; Müller O; Bannasch P; Schwarz M
    Mol Carcinog; 1992; 6(1):60-7. PubMed ID: 1323970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.
    Andreyev HJ; Ross PJ; Cunningham D; Clarke PA
    Gut; 2001 Feb; 48(2):230-7. PubMed ID: 11156646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and effects of Ha-ras codon 12 G-->A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus.
    Liston BW; Gupta A; Nines R; Carlton PS; Kresty LA; Harris GK; Stoner GD
    Mol Carcinog; 2001 Sep; 32(1):1-8. PubMed ID: 11568970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
    Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
    Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.